Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

GLEEVEC vs NINTEDANIB

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. GLEEVEC and NINTEDANIB are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

gleevecnintedanib

Rating

70/100
New

Pharmacy pays

~$25.80 /30
—

Type

RX
RX

Active ingredient

IMATINIB MESYLATE
NINTEDANIB

Manufacturer

Novartis
Teva Pharmaceuticals Development Inc

Dosage forms

Tablet
Capsule

Drug class

Kinase Inhibitor
Kinase Inhibitor

Boxed warning

None
None

Treats

Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome
Idiopathic Pulmonary Fibrosis

Frequently asked questions

What is the difference between Gleevec and Nintedanib?

Gleevec contains Imatinib Mesylate, while Nintedanib contains Nintedanib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.